The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...

Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges ...

Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to American rival Eli ...

The weight loss provided by CagriSema in Phase 3 trials beats current leading products for ... could further erode Novo's lead. FILE PHOTO: A view shows the logo of Novo Nordisk at the company's ...